Roche Prepared to Pay $66/Share for Illumina (ILMN) - Reports
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Illumina (ILMN) Off Highs as Faber Raises Questions
December 20, 2012 9:36 AM ESTIllumina Inc. (ILMN) backs off highs as CNBC David Faber was somewhat cautious on today's rumors from a France newspaper that Roche is prepared to bid $66/share. He said there has been nothing to back the reports up.
Shares last traded at $54.58, up 4.6%.... More
What Gene Sequencer is Roche (RHHBY) Aiming to Buy? (ILMN) (GENE)
December 20, 2012 6:17 AM ESTFollowing comments by Roche (OTCBB: RHHBY) CFO Alan Hippe earlier, gene sequencing stocks are on watch today.
Names include Hunman Genome (Nasdaq: GENE), Life Technologies (Nasdaq: LIFE), Illumina (Nasdaq: ILMN), Sequenom (Nasdaq: SQNM), Genomic Health (Nasdaq: GHDX), Hologic (Nasdaq: HOLX), and others.
For more on Hippe's comments, click here.... More
